Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Videra Surgical Inc. currently has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 2 pending office actions are assigned to 2 distinct examiners, meaning there is no examiner overlap for the company's active matters. The portfolio is active in 1 distinct art unit, which suggests that the technical subject matter is highly focused within a single department at the patent office.
The busiest examiner for this portfolio is CHOI, YOUNHEE JEON, who is currently overseeing 1 pending office action. Since there are 2 pending office actions in total, CHOI, YOUNHEE JEON and the other distinct examiner each handle exactly 1 pending office action. This distribution shows a balanced workload for the company's medical device innovations.
Managing 2 pending office actions within 1 distinct art unit allows the company to focus its legal strategy on the standards of a single department. However, because there are 2 distinct examiners, the company must still account for two different individual perspectives. Since CHOI, YOUNHEE JEON only manages 1 pending office action, the success of the portfolio is not concentrated with any single official in the Medical Devices & Mechanical Engineering space.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHOI, YOUNHEE JEON | 1 | 71.1% | +49.0% |
| DECASTRO, ARIANA JOY LACAY | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19248137 | AUTO CONTOURABLE RADIOPAQUE FIDUCIAL MARKER WITHOUT ARTIFACT | CHOI, YOUNHEE JEON | — |
| 18643613 | TISSUE MARKER WITH THERAPEUTIC PROPERTIES | DECASTRO, ARIANA JOY LACAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19248137 | AUTO CONTOURABLE RADIOPAQUE FIDUCIAL MARKER WITHOUT ARTIFACT | CHOI, YOUNHEE JEON | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19248137 | AUTO CONTOURABLE RADIOPAQUE FIDUCIAL MARKER WITHOUT ARTIFACT | CHOI, YOUNHEE JEON | 3797 | §103§112 | Final Rejection | — | Pending | Jun 24, 2025 |
| 18643613 | TISSUE MARKER WITH THERAPEUTIC PROPERTIES | DECASTRO, ARIANA JOY LACAY | — | §102§103§112 | Non-Final OA | — | Pending | Apr 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial